Form 4: Quest Diagnostics Executive Acquires Stock Options and Restricted Stock Units

Michael J. Deppe, SVP, Corp. Controller & CAO of Quest Diagnostics, reports acquisition of stock options and restricted stock units, along with adjustments to common stock holdings.

Summary

• Michael J. Deppe, a senior executive at Quest Diagnostics, filed a Form 4 detailing changes in beneficial ownership.
• On February 12, 2025, Deppe acquired 454 shares of common stock and 1,738 non-qualified stock options with an exercise price of $165.30.
• The stock options vest in three equal annual installments starting on February 12, 2026, and expire on February 12, 2035.
• Deppe also reported the disposal of 694 shares of common stock.
• Following these transactions, Deppe directly owns 35,399 shares of common stock and 1,738 stock options.
• Additionally, Deppe indirectly owns 694 shares through the company's 401(k) plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The acquisition of stock options is generally positive, but the disposal of shares introduces some uncertainty. The overall impact is likely minimal.

Positives

• The acquisition of stock options and restricted stock units by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.

Negatives

• The disposal of 694 shares of common stock by the executive could be interpreted negatively, although the reason for the disposal is not specified.

Risks

• The value of the stock options is dependent on the future performance of Quest Diagnostics' stock price.
• Market fluctuations could impact the value of the directly and indirectly held shares.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's prospects.

Comparison to Industry Standards

• Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
• The vesting schedule of the stock options (three equal annual installments) is a common practice in the industry.
• Comparing the size of the stock option grant to those of executives at comparable companies (e.g., Laboratory Corporation of America Holdings (LH)) would provide further context.

Stakeholder Impact

• The transactions reported in the Form 4 may have a minor impact on shareholder sentiment.
• The stock option grants incentivize the executive to improve company performance, potentially benefiting shareholders.

Key Dates